Related Experiment Video
Updated: May 14, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
RKIP: much more than Raf kinase inhibitory protein
Fahd Al-Mulla1, Milad S Bitar, Zainab Taqi
1Faculty of Medicine, Department of Pathology, Kuwait University Health Sciences Centre, Safat, Kuwait. fahd@al-mulla.org
Abstract:
From its discovery as a phosphatidylethanolamine-binding protein in bovine brain to its designation as a physiological inhibitor of Raf kinase protein, RKIP has emerged as a critical molecule for maintaining subdued, well-orchestrated cellular responses to stimuli. The disruption of RKIP in a wide range of pathologies, including cancer, Alzheimer's disease, and pancreatitis, makes it an exciting target for individualized therapy and disease-specific interventions. This review attempts to highlight recent advances in the RKIP field underscoring its potential role as a master modulator of many pivotal intracellular signaling cascades that control cellular growth, motility, apoptosis, genomic integrity, and therapeutic resistance. Specific biological and functional niches are highlighted to focus future research towards an enhanced understanding of the multiple roles of RKIP in health and disease.
Related Concept Videos
Receptor Tyrosine Kinases
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The JAK-STAT Signaling Pathway
Regulation of the Unfolded Protein Response
